VeriMomacetyl farnesylcysteine est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
Related ingredients
Frequently asked questions
- acetyl farnesylcysteine est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
- acetyl farnesylcysteine est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation‑related toxicity in the scientific literature or regulatory assessments. Dermal application to the breast could lead to low but measurable maternal systemic exposure (as for pregnancy), so exposure given as 1; no data show transfer into breastmilk or effects on nursing infants.
- acetyl farnesylcysteine est-il sûr pour la peau de bébé ?
- No infant‑specific toxicology found. Because topical AFC shows measurable activity/absorption in skin studies, baby exposure is increased by +1 to account for immature barrier and higher surface‑area‑to‑weight (adult e=1 → infant e=2). No data indicate infant‑specific hazard or mechanisms, so h and m remain 0.
- Comment VeriMom évalue-t-il acetyl farnesylcysteine ?
- VeriMom évalue acetyl farnesylcysteine à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à acetyl farnesylcysteine pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à acetyl farnesylcysteine basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.